Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 2	2026-08-03		NCT07742332

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Peng Zhang	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Shanghai Pulmonary Hospital	Shanghai	China	72

Clinical trials